Biogen France
Last update: August 6, 2020
Biotechnology
France
Its 6 main executivesRecent executive movements at Biogen
Michael McDonnell will join the company as Executive Vice President and Chief Financial Officer on Aug. 15, 2020 (news posted on July 22 2020).
Jeffrey Capello, Executive Vice President and Chief Financial Officer, will leave the company on Aug. 15, 2020 (news posted on July 22 2020).
Create an alert
to follow the executive moves at Biogen France.
Most searched biographies at Biogen France
- Martin Dubuc, Chief Executive Officer
- Naimi Missoum, Senior Director, Medical Affairs
- Javier Gonzalez, Director, Customer Excellence and Operations
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Syneos Health has announced the acquisition of SynteractHCR (posted on Dec 18, 2020).
Other contacts in the Biotechnology industry
Latest news about Biogen France
Biogen to Report Third Quarter 2020 Financial Results October 21, 2020 | Biogen
Biogen to Webcast Prerecorded Encore Aducanumab Presentation and Live Q&A from AAN 2020 Science Highlights on September 23, 2020 | Biogen
Biogen to Participate in the Morgan Stanley Virtual Global Healthcare Conference | Biogen
Biogen to Participate in SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum | Biogen
Biogen Presents Positive Phase 2 Cutaneous Lupus Erythematosus (CLE) Data at European E-Congress of Rheumatology (EULAR) 2020 | Biogen
Biogen France on Wikipedia, Google News & Yahoo Finance
Biogen France on LinkedIn, Twitter & YouTube
Biogen France has 1,539 competitors including Agilyx (United States (USA)), Eurofins (France) and Charles River Laboratories International (United States (USA)). Biogen France is owned by Biogen Europe.
Contact by email its executives including Martin Dubuc 
Call Biogen France at +33 14....
